# BYDUREON PEN
> **NDA022200** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2012-01-27
## Drug
- **FDA Application Number:** NDA022200
- **Application type:** New Drug Application
- **Brand name:** BYDUREON PEN
- **Generic name:** Exenatide Synthetic
- **Active ingredients:** EXENATIDE SYNTHETIC
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** ASTRAZENECA AB
- **First approval:** 2012-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022200)
---
*MORVS · CC0 1.0*